Search Results - "Armario‐Hita, J. C."

Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials by Barbarot, S., Wollenberg, A., Silverberg, J. I., Deleuran, M., Pellacani, G., Armario-Hita, J. C., Chen, Z., Shumel, B., Eckert, L., Gadkari, A., Lu, Y., Rossi, A. B.

“…Dupilumab, a first-in-class therapy targeting the two key cytokines involved in the persistent underlying inflammatory pathway in atopic dermatitis (AD), is…”
Get full text

Treatment of moderate‐to‐severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series by Armario‐Hita, J.C., Pereyra‐Rodriguez, J., Silvestre, J.F., Ruiz‐Villaverde, R., Valero, A., Izu‐Belloso, R., Jáuregui‐Presa, I., Curto‐Barredo, L., Figueras‐Nart, I., Herranz‐Pinto, P., Herraez‐Herrera, L., Ortiz‐de‐Frutos, F.J., Martinez‐Pilar, L., Sastre, J., Serra‐Baldrich, E.

Get full text

Assessing the value of moderate‐to‐severe atopic dermatitis treatment using multi‐criteria decision analysis (MCDA) by Pereyra‐Rodríguez, J. J., Poveda, J. L., Rivero, A., Serra‐Baldrich, E., Silvestre, J. F., Armario‐Hita, J. C., Calleja, M. Á., Carrascosa, J. M., Flórez, Á., Herranz, P., Comellas, M., Ortiz de Frutos, F. J.

Get full text

Drug survival of systemic and biological treatments for moderate‐to‐severe atopic dermatitis in adults: a multicentre retrospective observational study by Pereyra‐Rodriguez, J.J., Domínguez‐Cruz, J., Ruiz‐Villaverde, R., Silvestre, J.F., Galán, M., Curto, L., Figueras, I., Serra‐Baldrich, E., Armario‐Hita, J.C.

Get full text

Efficiency in patch testing: the number needed to test to get one relevant result as a new approach in the evaluation of baseline series by García‐Gavín, J., Mercader, P., Descalzo, M.A., Garcia‐Doval, I., Silvestre, J.F., Sánchez‐Pérez, J., Fernández‐Redondo, V., Armario‐Hita, J.C., Ruiz‐González, I., Giménez Arnau, A.

Get full text

Updated Review on Treatment of Atopic Dermatitis by Armario-Hita, J C, Galán-Gutiérrez, M, Dodero-Anillo, J M, Carrascosa, J M, Ruiz-Villaverde, R

“…Atopic dermatitis (AD) is a chronic or chronically recurrent Inflammatory dermatosis associated with multiple triggers that has a complex pathophysiological…”
Get full text

Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results by Pereyra-Rodriguez, J J, Herranz, P, Figueras-Nart, I, Perez, B, Elosua, M, Munera-Campos, C, Melgosa-Ramos, J, Zaragoza, V, Silvestre, J F, Campos-Domínguez, M, Guilabert, A, Miquel, J, Alcantara-Luna, S, Serra-Baldrich, E, Armario-Hita, J C

Get full text

Infliximab for the treatment of hidradenitis suppurativa by Fernández-Vozmediano, J M, Armario-Hita, J C

“…Hidradenitis suppurativa is a chronic inflammatory disease characterized by significant morbidity. Current medical therapies are usually only minimally…”
Get more information

Cutaneous endometriosis by Fernández Vozmediano, J. M., Armario Hita, J. C., Cuevas Santos, J.

“…A 32‐year old patient presented with an asymptomatic, non‐specific tumour located at the site of a previous cesarian scar. The tumor had never bled but its…”
Get full text

Unveiling the true costs and societal impacts of moderate‐to‐severe atopic dermatitis in Europe by Augustin, M., Misery, L., Kobyletzki, L., Armario‐Hita, J.C., Mealing, S., Redding, M.

“…Atopic dermatitis (AD) is a chronic, auto‐immune condition that imposes a high burden on individuals, society, and the healthcare system. Approximately 4.4% of…”
Get full text

[Translated article] Efficacy and Pharmacoeconomic Analysis in Real Clinical Practice Conditions of Patients with Plaque Psoriasis Treated with Guselkumab: A Retrospective Multicenter Study by Ruiz-Villaverde, R, Galan-Gutierrez, M, Armario-Hita, J C, Rodriguez-Fernandez-Freire, L

Get full text

Allergic contact dermatitis in children by Fernández Vozmediano, JM, Armario Hita, JC

“…ABSTRACT Introduction  Allergic contact dermatitis (ACD) is equally as likely in infancy as in adulthood, and represents 20% of all cases of dermatitis in…”
Get full text

Dupilumab: short‐term effectiveness and security in real clinical practice – A retrospective multicentric study by Ruiz‐Villaverde, R., Dominguez‐Cruz, J., Armario‐Hita, J.C., Martinez‐Pilar, L., Alcantara‐Luna, S., Pereyra‐Rodriguez, J.J.

Get full text

Consensus on the diagnostic algorithm for chronic nodular prurigo by Ortiz de Frutos, J, Serra Baldrich, E, Tribó Boixareu, M J, Armario Hita, J C, Carrascosa Carrillo, J M, Nart, I Figueras, Menéndez, Á Flórez, Pinto, P Herranz, Francisco Silvestre, J

“…Chronic nodular prurigo (CNP) is a chronic dermatological disease characterized by the presence of chronic pruritus and pruritic nodular lesions. The aim of…”
Get full text

Sjögren-larsson syndrome: treatment with topical calcipotriol by Fernández-Vozmediano, J. M., Armario-Hita, J. C., González-Cabrerizo, A.

Get full text

[Translated article] Efficacy and Pharmacoeconomic Analysis in Real Clinical Practice Conditions of Patients with Plaque Psoriasis Treated with Guselkumab: A Retrospective Multicenter Study by Ruiz-Villaverde, R., Galan-Gutierrez, M., Armario-Hita, J.C., Rodriguez-Fernandez-Freire, L.

Get full text

Allergic contact dermatitis from diallyl disulfide by FERNANDEZ-VOZMEDIANO, J. M, ARMARIO-HITA, J. C, MANRIQUE-PLAZA, A

Get full text

[Translated article] Patient-Reported Outcome Measures in Real-World Atopic Dermatitis Studies in Spain: A Systematic Review by Armario-Hita, J C, Artime, E, Vidal-Vilar, N, Huete, T, Díaz-Cerezo, S, Moro, R M, Lizán, L, Ortiz de Frutos, F J

“…Atopic dermatitis (AD) is a chronic inflammatory skin disease with symptoms such as pruritus that can be a major burden for patients. Patient-reported outcomes…”
Get full text

Secukinumab: Drug Survival in Clinical Practice Settings by Ruiz-Villaverde, R., Rodriguez Fernández-Freire, L., Galán-Gutiérrez, M., Armario-Hita, J.C., Martinez-Pilar, L.

“…Secukinumab, an immunoglobulin G1/κ monoclonal antibody that selectively targets interleukin 17a, is used to treat moderate to severe plaque psoriasis in…”
Get full text

Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas by Izu-Belloso, R., Gainza-Apraiz, I., Ortiz-Romero, P., Servitje-Bedate, O., Fernández de Misa-Cabrera, R., Peñate, Y., Hernandez-Machin, B., Estrach-Panella, T., Llamas-Velasco, M., Yanguas-Bayona, J.I., Morillo-Andujar, M., Acebo-Mariñas, E., Perez-Gala, S., Armario-Hita, J.C., Sanchez-Sambucety, P., Ortiz-Brugues, A., Eguren-Michelena, C., Bielsa-Marsol, I., Lopez-Pestaña, A., Blanes-Martinez, M., Fernandez-Guarino, M., Lopez-Lerma, I.

“…Bexarotene has been approved to treat advanced stage cutaneous T-cell lymphomas (CTCL) since 1999. However, very few data have been published on its long-term…”
Get full text